Your institution may have access to this item. Find your institution then sign in to continue.
Title
Galderma Introduces New Treatment for Rosacea.
Abstract
The article reports that Galderma Laboratories LP has received an approval from the U.S. Food and Drug Administration for its MetroGel® Topical Gel as treatment for inflammatory lesions of rosacea. This medication, which incorporates a higher concentration of metronidazole, allows for once-a-day dosing as opposed to twice-a-day for most other topical rosacea treatments.